HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD Draws Line Between Puffery, Substantive Claims In Pink Armor Case

This article was originally published in The Rose Sheet

Executive Summary

Ontel should discontinue its use of “before” and “after” images in Pink Armor Nail Gel advertising, as the dramatic results depicted need to be supported with reliable scientific evidence, the National Advertising Division says. The industry self-regulatory body agrees with challenger Coty that Ontel’s claims are not mere puffery and that consumer accounts of their experiences with the product are not adequate substantiation.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019010

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel